Protocol-defined biomarker analysis in the PALLAS (AFT-05) adjuvant trial: genomic subtype derived from RNA sequencing of HR+/HER2- early breast cancer.
- Citation:
- Meeting Instance:
- SABCS 2023
- Year:
- 2023
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- AFT
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Breast
- Sec. Committees:
- Correl Sci NOS
- Pharmas:
- Pfizer
- Grants:
- Corr. Author:
- Authors:
- Daniel Stover Dominik Hlauschek Erica L Mayer W Fraser Symmans Mark Watson Iros Barozzi Martin Filipits Karla Ballman Merritxell Bellet-Ezquerra Justin Balko Gabor Rubovszky Nick Zdenkowski Adam Brufsky Guenther Steger Claudine Isaacs Sibylle Loibl Fernando Henao Carrasco Carsten Denkert Meredith Regan Yuan Liu Christian Fesl Patrick O'Brien Angela DeMichele Michael Gnant Otto Metzger
- Networks:
- CAPITAL, LAPS-MA036, LAPS-MO011, LAPS-OH007, LAPS-PA015, LAPS-TX035, OH070
- Study
- AFT-05
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: